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Abstract
Objective: To assess incidence and possible risk factors of severe maternal morbidity and mortality from cardiovascular
disease in the Netherlands.
Design: A prospective population based cohort study.
Setting: All 98 maternity units in the Netherlands.
Population: All women delivering in the Netherlands between August 2004 and August 2006 (n = 371,021)
Methods: Cases of severe maternal morbidity and mortality from cardiovascular disease were prospectively collected during
a two-year period in the Netherlands. Women with cardiovascular complications during pregnancy or postpartum who were
admitted to the ward, intensive care or coronary care unit were included. Cardiovascular morbidity was defined as
cardiomyopathy, valvular disease, ischaemic heart disease, arrhythmias or aortic dissection. All women delivering in the
same period served as a reference cohort.
Main outcome measures: Incidence, case fatality rates and possible risk factors.
Results: Incidence of severe maternal morbidity due to cardiovascular disease was 2.3 per 10,000 deliveries (84/358,874).
Maternal mortality rate from cardiovascular disease was 3.0 per 100,000 deliveries (11/358,874). Case fatality rate in women
with severe maternal morbidity due to cardiovascular disease was 13% (11/84). Case fatality rate was highest in aortic
dissection (83%). Pre-existing acquired or congenital heart disease was identified in 34% of women. Thirty-one percent of
women were of advanced maternal age (.35 years of age) and 5 percent above 40 years of age. Possible risk factors for
cardiovascular morbidity were caesarean section (either resulting in or as a result of cardiovascular disease), multiple
pregnancy, prior caesarean section, non-Western ethnicity and obesity.
Conclusions: In the Netherlands cardiovascular disease is a rare cause of severe maternal morbidity with an incidence of 2.3
per 10,000 deliveries and a high case fatality rate of 13%. Cardiovascular complications develop mostly in women not
known with cardiac disease pre-pregnancy.
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Introduction
Cardiovascular disease complicates approximately 1–3% of
pregnancies and is responsible for 10 to 15% of maternal
mortality.[1–3] Since more women with congenital and acquired
heart disease reach fertile age due to improved medical care, the
incidence of cardiovascular disease in pregnancy is increasing.
The UK Confidential Enquiries into Maternal and Child
Health have identified cardiovascular disease as an increasingly
important cause of indirect maternal death. Increasing prevalence
of advanced maternal age, obesity and pre-existing hypertension
constitute risk factors for the development of cardiovascular
disease during pregnancy. In the last two triennia ending in 2005
and 2008, cardiac disease was the most frequent cause of indirect
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maternal death with a maternal mortality rate (MMR) of 2.27 and
2,31 per 100,000 maternities, respectively.[3]
Although there was a decline in maternal deaths related to
congenital heart disease (CHD) from 4.6 per million to 1.3 per
million maternities in the triennia ending in 1996 and 2008,
maternal mortality from acquired heart diseases (AHD) increased
from 3.8 per million in 1996 to 21.8 per million maternities in
2008.[3–6]
In the Netherlands, cardiovascular disease was the main cause
of indirect maternal mortality (MMR 1.6 per 100,000 live births)
between 1993 and 2005, and significantly increased as compared
to 1983 to 1992, when it was the second most frequent cause
(MMR 0.6 per 100,000 live births; OR 2.5; 95% CI 1.4–4.6) after
cerebrovascular disorders. Indirect maternal deaths are those
resulting from previously existing disease or disease that develops
during pregnancy, not due to direct obstetric causes, but which is
aggravated by physiologic effects of pregnancy. When looking at
all causes of maternal mortality, cardiovascular disease rose from
the fourth to the second most frequent cause after (pre-)
eclampsia.[7]
Pregnancy represents a major stress to the cardiovascular
system, not only due to a 50% increase in blood volume and
cardiac output and a decrease in systemic vascular resistance, but
also due to structural changes in the vascular wall such as
hypertrophy of vascular endothelium and smooth muscle and a
higher risk of thrombosis. This explains why women with heart
disease may experience deterioration of clinical function or even
develop heart failure during pregnancy and have a higher
complication rate.
In this nationwide study we aimed to investigate the incidence
and possible risk factors of severe maternal morbidity from
cardiovascular disease and its case fatality rate (CFR) during
pregnancy, both in women with or without pre-existing heart
disease.
Methods
Study Design
All cases of severe maternal morbidity and mortality were
collected in a nationwide cohort study called the LEMMoN-study,
conducted between August 1st 2004 and August 1st 2006. Detailed
methods are described elsewhere.[8]
Data source
All 98 hospitals in the Netherlands with a maternity unit
participated in this study. Monthly, local coordinators reported all
cases using standardized web-based forms. Inclusion criteria were
one or more of the following during pregnancy, delivery or
puerperium: ICU/CCU admission; uterine rupture; eclampsia;
major obstetric haemorrhage; other rare severe maternal morbid-
ity to the opinion of the treating clinician. In the respective
hospitals, cases were identified using maternity computer data-
bases, labour ward diaries, staff reports, intensive care admission
registers, blood transfusion registers, admission and discharge
letters, letters concerning preconceptional advice and personal
communication. Obtained data were made anonymous and
consisted of a case record form with photocopies of relevant parts
of the patient files such as those mentioned above.[8]
Sample selection
From this cohort (n = 2552), the following women were selected
from the database for the current study: 1) women admitted to
intensive care unit (ICU) or coronary care unit (CCU) for
cardiovascular disease during pregnancy, delivery and puerperium
(limited to six weeks); 2) women on the ward with serious maternal
morbidity from cardiovascular disease according to the treating
physician, but not requiring ICU or CCU admission; 3) women
who died before reaching ICU or CCU because of cardiovascular
disease. Cases in which cardiovascular disorders were secondary to
other complications (i.e. cardiac arrest after major pulmonary
embolism) were excluded. All cases were discussed by the authors
and placed in one of the categories when definitions were met.
Women with pre-existing cardiovascular disease who had a
normal, uneventful pregnancy, delivery and puerperium were
not eligible for inclusion and remain beyond the scope of this
study.
Cardiovascular disorders were categorized as: cardiomyopathy,
valvular disease, ischaemic heart disease, arrhythmias and aortic
dissection. Congenital heart disease was not a separate category
due to small numbers and women were placed into the most
appropriate category.
Peripartum cardiomyopathy (PPCM) was defined, according to
Sliwa et al., as ‘an idiopathic cardiomyopathy presenting with
heart failure secondary to left ventricular (LV) systolic dysfunction
towards the end of pregnancy or in the months following delivery,
where no other cause of heart failure is found. It is a diagnosis of
exclusion. The LV may not be dilated but the ejection fraction
(EF) is nearly always reduced below 45%’. [9] Hypertrophic
cardiomyopathy was defined as echographically proven hypertro-
phied, non-dilated left ventricle in the absence of another systemic
or cardiac disease that is capable of producing the same magnitude
of wall thickening. Dilated cardiomyopathy was defined as an EF
of ,40% in the presence of increased left ventricular dimension,
without other cause. Where possible, cases of arrhythmia were
further specified as supraventricular tachycardia (SVT) or
ventricular tachycardia (VT). SVT was defined as any tachycardia
that was not ventricular in origin (ectopic atrial tachycardia, atrial
fibrillation, atrial flutter and junctional tachycardia). VT was
defined as tachycardia with ventricular origin, based on a 12-lead
electrocardiography (ECG). Valvular disease was defined as
cardiac valve stenosis or regurgitation when the diagnosis was
made upon a heart murmur and symptoms in combination with
echocardiographic abnormalities. Valvular disease was further
specified into CHD, rheumatic disease or endocarditis based on
the origin of valvular dysfunction. Ischaemic heart disease was
defined as maternal complaints of chest pain accompanied by
either rise of cardiac markers or ECG changes. Acute coronary
syndrome was proven by raised cardiac markers (troponin
.0.3 ug/l or CK-MB.170 U/l) in combination with complaints
or ECG abnormalities. ST-depressions are known to occur rather
frequently during caesarean section.[10] These mild ECG
abnormalities in the absence of any abnormal clinical or
laboratory findings were considered mild maternal morbidity
and hence not included in the LEMMoN study. Sudden
Arrhythmic (or Adult) Death Syndrome (SADS) is defined as
sudden death in an adult for which no cause could be found.
Maternal deaths reported during the study period were cross-
checked with the national Maternal Mortality Committee of the
Dutch Society of Obstetrics and Gynaecology (NVOG). All
maternal deaths due to cardiovascular disease were included.
Results of post-portem investigations were collected, when
available.
Maternal characteristics such as age, socio-economic status,
body mass index (BMI), geographical ethnic origin and parity were
collected, as well as all data on pregnancy and delivery and
puerperium, including complications. Medical history was scruti-
nized for congenital heart disease, defined as structural or
functional abnormality of the heart or intrathoracic great vessels
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that is present at birth and acquired heart disease, defined as a
structural or functional abnormality of the heart that is acquired
later in life. Cardiac risk factors such as smoking, hypertension,
diabetes, hypercholesterolaemia (defined as total cholesterol
$6.5 mmol/l) and a positive family history of cardiac disease
under 60 years of age were identified.
Outcome definitions
Main outcome measures were incidence of cardiovascular
disorders and their respective CFRs.
Incidence was calculated using the total number of births in the
Netherlands during the study period as denominator. Denomina-
tor data for the number of deliveries in the Netherlands were
obtained from Statistics Netherlands (CBS) and based on birth
registries after correction for stillbirths after 24 weeks of gestation
and multiple pregnancies.[11] CFRs were calculated by dividing
the number of deaths due to a specific condition by the total
number of women with severe morbidity from that specific
condition.
Possible risk factors for cardiac disorders in pregnancy were
identified by calculating relative risks (RR) and 95% confidence
intervals (CI) compared to the general pregnant Dutch population.
National reference values, serving as the ‘comparison group’ were
obtained from Statistics Netherlands and the Netherlands Perina-
tal Registry (LVR), a national registry containing outcome
information of all pregnancies and deliveries from both midwives,
obstetricians and general practitioners.[12]
Statistical analyses
The data for the comparison group that was obtained from the
LVR were used as reference values for calculating relative risk
factors. Relative risks and confidence intervals were calculated in
univariable analysis. Because the data only provided characteris-
tics of all maternities together, we could not adjust relative risks for
confounding variables, nor was a multivariable analysis possible.
Differences between groups were identified using Chi square test,
significance was defined as p,0.05. Statistical analyses were
performed using Statistical Package for Social Sciences, version
17.0 (SPSS Inc, Chicago, IL, USA). The medical ethics committee
of Leiden University Medical Center approved the LEMMoN
study (P04-020; 8 March 2004).
Results
All 98 maternity hospitals in the Netherlands reported a total of
2275 ‘hospital months’. Due to delayed participation of some
hospitals, the LEMMoN study represented 97% of all deliveries in
the study period (358,874 deliveries). Of the 2552 cases of severe
maternal morbidity in the LEMMoN study, 84 (3.3%) involved
cardiovascular disease. The incidence was 2.3 per 10,000
deliveries in the Netherlands.
There were 11 cases of maternal death due to cardiovascular
disease, an incidence of 3.0 per 100,000 deliveries. CFR among
women with severe morbidity from cardiovascular disorders of
pregnancy was 13.1% (11/84), with nearly half of maternal deaths
being caused by aortic dissection (Table 1). Of the 11 maternal
deaths, one woman was known with congenital valvular disease,
one with Marfan syndrome and one with hypertension. There
were three maternal deaths among the 28 women with pre-
existing acquired or congenital heart disease that experienced
severe morbidity during pregnancy, delivery and puerperium
(CFR 11%). Five women died during pregnancy, the other six
postpartum.
Pre-existing acquired or congenital heart disease was identified
in 34% of women. Most cardiovascular disease during pregnancy,
delivery and puerperium thus occurred in women without pre-
existing cardiac disease. Anticoagulants or medication for
arrhythmias and/or hypertension before and/or during pregnancy
was used by 20% of all women. Information concerning cardiac
risk factors and previous (cardiac) history was available in 70% of
women. Thirty-one percent of the women with cardiovascular
disease were over the age of 35 yrs at the moment of inclusion and
nearly 5% over the age of 40 yrs.
At least one cardiac risk factor of smoking, hypertension,
overweight or obesity, diabetes, hypercholesterolaemia, or a family
member with an acute coronary syndrome at a young age was
present in 39% of the women. Of the women with a known BMI,
19% were overweight, 9% obese and 10% morbidly obese
(Table 2).
In 8% of cases, the cardiovascular disorder occurred in early
pregnancy, in 46% antepartum, in 10% during labour or
caesarean and in 36% postpartum. Mode of delivery is shown in
Table 3.
Comparing possible risk factors for developing cardiovascular
disorders with reference to national data are shown in Table 4.
[11–14] Associated factors in univariable analysis were caesarean
section (RR 8.2, 95% CI 5.6–12.9), multiple pregnancy (RR 6.0,
95% CI 2.7–12.8), prior caesarean section (RR 2.9, 95% CI 1.5–
5.4), non-Western ethnicity (RR 2.4, 95% CI 1.4–3.9) and obesity
(RR 2.3, 95% CI 1.1–4.6).
Of the 84 women with cardiovascular disease, 70 (83%) were
admitted to ICU or CCU. Five women were being resuscitated or
already dead upon arrival in hospital.
Preconceptional advice was given in 21% (6/28) of women with
pre-existing cardiac disease. It remained unclear whether or not
preconceptional advice was given for 9 women. There was a high
index of suspicion of cardiac disease in 14% (12/84) of women. In
these cases, either patient (n = 3) or doctors delay (n = 9) may have
played a role in the progression of adverse outcomes.
Multidisciplinary consultation between obstetricians and cardi-
ologists or anaesthesiologists took place in 86% (32/37) of women
with antepartum cardiac disease. Most important topics were
expected tolerance of cardiac strain during labour and endocar-
ditis prophylaxis. Measures agreed upon included endocarditis
prophylaxis (n = 9), primary epidural analgesia (n = 5), telemetry
during delivery (n = 4), termination of pregnancy (n= 2) and
primary instrumental delivery (n = 2).
During the study period, 19 women experienced cardiac arrest
with a CFR of 63%. Nine of them were included in the current
study group with primary cardiovascular disease. These had
cardiac arrest preceded by aortic dissection (n= 4), arrhythmia
(n = 2), SADS (n = 2) and spinal anaesthesia in combination with
pre-existing cardiomyopathy (n= 1). Excluded were those that had
cardiac arrest preceded by non-primary cardiovascular disease.
Cardiomyopathy
Twenty-three women experienced cardiomyopathy, including
17 women with PPCM. Among the 12 antepartum cases, mean
onset of disease was at 34 weeks gestation. Ten of the 17 women
with PPCM either had pregnancy induced hypertension (PIH),
pre-eclampsia (PE) or HELLP syndrome. Six women admitted to
the ICU or CCU were intubated for mechanical ventilation
followed by emergency caesarean section. Two women developed
terminal heart failure requiring bridge-to-transplant therapy
(heartmate, left ventricular assist device) followed by an Implant-
able Cardioverter Defibrillator (ICD) in one woman and heart
transplant in the other. There were two maternal deaths (CFR
Maternal Morbidity from Cardiovascular Disease
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8.7%): both due to postanoxic encephalopathy, the first after
cardiogenic shock despite introduction of an intra-aortic balloon
pump and the other after ventricular fibrillation and cardiopul-
monary resuscitation (CPR). Complications occurred after major
obstetric haemorrhage in two women.
Valvular disease
Nineteen women developed symptomatic valvular disease with
two-thirds (13/19) presenting antepartum with median onset at 30
weeks gestation. The four women with valvular disease based on
previous acute rheumatic fever were all from Mediterranean
descent. Three had mitral valve stenosis and one suffered from
aortic stenosis. Four other women had aortic stenosis or aortic-,
mitral- or tricuspid regurgitation based on CHD. There were five
women with cardiac valve prostheses including two biological and
three mechanical prostheses. All three women with mechanical
prostheses developed thromboembolic complications, two after
anticoagulant therapy switch and one without therapy switch. Two
women with a biological prosthetic heart valve developed
arrhythmia after mild postpartum haemorrhage. Two of the five
women who were admitted antepartum subsequently delivered at
the ICU or CCU. Although there was no maternal death in this
category, there was significant long-term morbidity. Three women
developed heart failure, three arrhythmias and one woman with a
mechanical valve developed both. Two women with arrhythmia
received direct current cardioversion several weeks postpartum.
One woman with secondary heart failure required mitral and
aortic valve surgery six weeks postpartum.
Ischaemic heart disease
Seventeen women developed ischaemic heart disease (IHD),
including ten women with acute coronary syndrome (ACS). Mean
onset of disease was almost exclusively intrapartum or directly
postpartum at a median gestation of 40 weeks. IHD developed
after the use of ritodrine (Pre-ParH) in three women. Complica-
tions occurred after major obstetric haemorrhage in five women,
four of whom had been given sulproston (NaladorH). Treatment or
diagnostic modalities included percutaneous transluminal coro-
nary angioplasty (PTCA) (n = 3), coronary angiography (n= 2) and
drug administration (n= 3). There was one maternal death (CFR
5.9%). She was admitted to the CCU six weeks postpartum in
cardiogenic shock. Despite CPR and PTCA, death occurred due
to dissection of the left anterior descending coronary artery as
confirmed at postmortem.
Arrhythmias
Sixteen women experienced cardiac arrhythmias, including 11
SVTs and 5 VTs. SVTs included Wolff-Parkinson-White
syndrome (n= 2), atrial fibrillation (n= 2), after major obstetric
haemorrhage (n = 3) or were not further specified in the other four
women. Onset of disease was mostly antepartum (n= 9) with a
median onset at 33 weeks gestation. There was one maternal death
Table 1. Types of cardiovascular disease and its mortality.
Type of cardiovascular disease Morbidity n (% of total) Mortality n (CFR)
Cardiomyopathy 23 (27.4) 2 (9%)
PPCM 17 1
hypertrophic CM 1
dilated CM 2
other, unspecified, pre-existing CM 3 1
Valvular Disease* 19 (22.6) 0
CHD 4
rheumatic heart disease or fever 4
endocarditis 1
mechanical or biological valve 5
other valvular disease 5
Ischaemic heart disease 17 (20.2) 1 (6%)
General ischaemia 7
ACS 10 1
- related to ritodrine (Pre-parH) 3
- coronary artery dissection 1
Arrhythmias 16 (19.0) 1 (6%)
SVT 11
VT 5 1
Aortic dissection 6 (7.1) 5 (83%)
Miscellaneous 3 (3.6) 2 (67%)
pericarditis 1
SADS 2 2
Total 84 (100) 11 (13%)
*more than one subcategory possible. PPCM: peripartum cardiomyopathy; CM: cardiomyopathy; CHD: congenital heart disease; ACS: acute coronary syndrome; SVT:
supraventricular tachycardia; VT: ventricular tachycardia; SADS: Sudden Arrhythmic Death Syndrome.
doi:10.1371/journal.pone.0056494.t001
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Table 2. Characteristics of women with severe maternal morbidity caused by cardiovascular disease.
Characteristic
(PP)CM
n=23
VALVE
n=19 IHD n=17
ARR
n=16
AD
n=6
MISC
n=3
TOTAL
n=84 %
Age (mean 31.5)
,20 year 1 1 0 0 0 0 2 2.4
20–34 year 13 12 12 13 3 3 56 67
35–39 year 8 5 3 3 3 0 22 26
$40 year 1 1 2 0 0 0 4 4.8
Socio-economic status indicator
Low 5 11 5 3 1 0 25 36
Middle 12 4 5 7 3 3 34 49
High 3 2 2 3 1 0 11 16
Unknown 3 2 5 3 1 0 14
Smoking during pregnancy
Yes 0 0 2 1 0 2 5 9.8
No 12 10 12 10 2 0 46 90
Unknown 9 9 3 5 4 1 31
Body Mass Index (kg/m2)
,18.5 0 1 0 1 0 1 3 5.1
18.5–24.9 10 8 6 7 2 1 34 58
25–29.9 (overweight) 3 3 2 2 1 0 11 19
30.0–34.9 (obese) 2 0 1 2 0 0 5 8.5
$35 (morbidly obese) 4 0 1 0 1 0 6 10
Unknown 4 7 7 4 2 1 25
Geographical ethnic origin
Western 18 9 14 10 6 3 60 71
Non-Western 5 10 3 6 0 0 24 29
Prior Heart Disease*
Yes 5 14 2 5 2 0 28 34
Acquired 3 10 1 4 2 0 20
Congenital 2 4 1 1 0 0 8
No 19 5 15 10 3 3 54 66
Unknown 0 0 0 1 1 0 2
Prior Cardiac Medication‘
none 19 11 15 13 6 3 67 80
diuretic 1 2 0 0 0 0 3 3.6
anti-arrhythmic or b-blocker 3 4 2 2 0 0 11 13
anti-coagulant 3 5 0 0 0 0 8 9.5
ACE inhibitor 1 0 0 1 0 0 2 2.4
Comorbidity
Diabetes
Type I 1 2 0 0 0 0 3 3.6
Type II 0 0 1 0 0 0 1 1.2
Gestational diabetes 1 0 0 0 0 0 1 1.2
No 21 17 16 16 6 3 79 94
Hypertensive disease
(pre-)eclampsia 9 5 1 1 0 0 16 19
pregnancy induced 2 0 0 2 1 0 5 6
pre-existing 1 2 2 0 1 0 6 7.1
No 10 13 14 13 5 3 58 69
Positive family history of heart disease
Yes 3 1 0 1 0 0 5 10
Maternal Morbidity from Cardiovascular Disease
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(CFR 6.3%) eight days postpartum after cardiac arrest based on
ventricular fibrillation for which cardiac catheterization and
insertion of an intra-aortic balloon pump was performed. Two
women with ventricular tachycardia required ICD implantation,
which was placed postpartum. Pharmacological or electrical
cardioversion was performed in seven and five women, respec-
tively.
Aortic dissection
Six women had aortic dissection, five of whom died
(CFR=83%). Three women died before delivery and two shortly
after emergency caesarean section. Presentation was at a median
gestation of 34 weeks. At 24 weeks gestation, ascending aorta
dilation measured 57 mm in a woman with Marfan syndrome.
She died five days postpartum during emergency surgery for aortic
dissection due to pulmonary artery rupture.
Miscellaneous
A primiparous woman was admitted at 33 weeks gestation with
hemolysis, elevated liver enzymes, low platelets (HELLP) syn-
drome, progressive acute respiratory distress syndrome and
pneumonia. After emergency caesarean section, her ECG was
indicative of pericarditis secondary to pneumonia.
SADS occurred in two women. One perimortem caesarean
section was performed in the delivery room in a term multiparous
woman after acute collapse. Postmortem investigation did not
reveal exact cause of death but did show goiter (91 grams) and
congested hepatomegaly (2320 grams). There were no signs of
acute coronary syndrome or lung or amniotic fluid embolus. Based
on the clinically seen acute cyanosis and congested liver, the cause
of death was considered of cardiac origin. Another primiparous
woman was found at 23 weeks gestation and died after
resuscitation. Postmortem investigation showed fibrosis of the
interstitial wall of the left ventricle and all organs showed extreme
hyperaemia, indicating possible terminal heart failure. Traces of
cannabis were also found, although this was of unsubstantial
Table 3. Obstetric history and mode of delivery in women with severe maternal morbidity caused by cardiovascular disease.
Characteristic
(PP)CM
n=23 VALVE n=19
IHD
n=17
ARR
n=16
AD
n=6 MISC n=3 TOTAL n=84 %
Obstetric history
prior caesarean section 2 4 3 3 1 0 13 15.5
parity 0 16 10 9 8 2 2 47 56.0
parity 1–2 5 7 7 8 4 1 32 38.1
parity $3 2 2 1 0 0 0 5 6.0
Current pregnancy
singleton pregnancy 20 17 16 16 4 3 76 90.5
multiple pregnancy 3 2 1 0 2 0 8 9.5
artificial reproduction techniques: IVF/ICSI 1 0 0 0 1 0 2 2.4
Delivery
spontaneous delivery 4 5 5 8 0 0 22 26.2
ventouse/forceps delivery 2 2 2 1 0 0 7 8.3
induction of labour 6 6 2 2 0 0 16 19.0
pre-labour caesarean section 13 7 2 4 3 1 30 35.7
caesarean section overall 17 10 9 5 3 2 46 54.8
breech presentation 3 1 1 1 0 0 6 7.1
preterm birth (,37 w) 13 10 3 3 2 1 32 38.1
post term birth ($42 w) 2 0 1 0 0 0 3 3.6
ICU or CCU admission 23 16 14 14 2 1 70 83.3
(PP)CM: (peripartum) cardiomyopathy, VALVE: valvular disease, IHD: ischaemic heart disease, ARR: arrhythmias, AD: aortic dissection, MISC: miscelaneous.
doi:10.1371/journal.pone.0056494.t003
Table 2. Cont.
Characteristic
(PP)CM
n=23
VALVE
n=19 IHD n=17
ARR
n=16
AD
n=6
MISC
n=3
TOTAL
n=84 %
No 14 10 10 6 0 0 40 83
Unknown 6 8 7 9 6 0 36
*not including pregnancy-induced hypertension or (pre) eclampsia,
‘more than one option possible. (PP)CM: (peripartum) cardiomyopathy, VALVE: valvular disease, IHD: ischaemic heart disease, ARR: arrhythmias, AD: aortic dissection,
MISC: miscellaneous.
doi:10.1371/journal.pone.0056494.t002
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amount to explain this death. Based on these findings, cardiac
origin as a cause of death was most likely.
Discussion
In this study we report all severe cardiac disorders of pregnancy
and childbirth in a two-year nationwide cohort. Most severe
maternal morbidity from cardiac disorders occurs in women
without pre-existing cardiac disease. Our incidence of severe
maternal morbidity from cardiovascular disease of 2.3 per 10,000
deliveries is much lower than the ratios of 0.2–4% presented in the
ESC Guidelines on the management of cardiovascular disease
during pregnancy by the Task Force of the European Society of
Cardiology (ESC).[15] The Netherlands, considered a developed
country, may have possibly better outcomes compared to
developing countries.[16] However, the ESC percentages concern
pregnancies complicated by cardiovascular disease, not severe
maternal morbidity as was the aim of our study. For example,
women with pre-existing disease who did not experience severe
maternal morbidity were not captured in this study. Women with
pre-existing congenital or acquired cardiovascular disease that
developed severe maternal morbidity represented 34% of this
cohort, half of them concerning women with arrhythmias.
Other studies have found that maternal mortality due to
cardiovascular disease has increased over the last decade. It can be
assumed that severe morbidity due to cardiovascular disease is also
increasing. This coincides with cardiac risk factors such as
increasing maternal age and obesity incidence in the general
Dutch population. Another determinant may be the fact that more
women with CHD reach childbearing age due to advances in
treatment. Cardiovascular complications are reported in 11% of
pregnancies in women with different types of CHD.[17] A
prospective follow-up study of all women with CHD is currently
being performed in the Netherlands under the name of
‘ZAHARA-II’.[18]
The increase in maternal deaths from cardiovascular disease in
the Netherlands is similar to findings in the UK.[7] In the
Netherlands, the mean age at first pregnancy in 2006 was 29.4
years of age, a five-year increase compared to 1970. In 2006, 7.0%
of women had their first pregnancy after their thirty-sixth
Table 4. Comparison of possible risk factors for developing severe maternal morbidity and mortality caused by cardiovascular
disease between cases and the general pregnant population.
Cases n=84 Netherlands, general pregnant population n=358,874
Possible risk factor (%) (%) RR (95% CI)
patient
age $35 years 31.0 24.7** 1.4 (0.8–2.2)
age $40 years 4.8 3.4** 1.4 (0.4–3.9)
BMI ,18.5 kg/m2 5.1 3.1** 1.7 (0.4–5.5)
BMI $25 kg/m2 (overweight) 37.3 31.7** 1.3 (0.7–2.2)
BMI $30.0 kg/m2 (obese) 18.6 9.8** 2.3 (1.1–4.6)
BMI $35 kg/m2 (morbidly obese) 10.2 n/a
low income 35.7 n/a
non-Western immigrants 28.6 16.8 2.4 (1.4–3.9)
smoking during pregnancy 9.8 n/a
single household 2.4 n/a
chronic disease in history* 39.3 n/a
pregnancy
prior caesarean section 15.5 6.013 2.9 (1.5–5.4)
multiple pregnancy 9.5 1.7** 6.0 (2.7–12.8)
parity 0 56.0 45.2** 1.5 (1.0–2.4)
parity $3 6.0 5.0** 1.2 (0.4–3.1)
artificial reproduction techniques: IVF/ICSI 2.4 1.914 1.2 (0.2–5.1)
delivery
ventouse/forceps delivery 8.3 8.6*** 1.0 (0.4–2.2)
induction of labour 19.0 12.5*** 1.8 (1.0–3.1)
pre-labour caesarean section 35.7 5.9*** 9.0 (5.6–14.4)
caesarean section overall 54.8 13*** 8.2 (5.6–12.9)
breech presentation 7.1 4.9*** 1.5 (0.6–3.6)
preterm birth (,37 w) 38.1 5.8*** 10.3 (6.5–16.3)
post term birth ($42 w) 3.6 4.3*** 0.8 (0.2–2.7)
n/a = data not available. RR = relative risk (95% confidence interval) significant.
*includes hypertension, diabetes, cardiac disease and coagulation disorders. National reference values from.
**[11] Statistics Netherlands (exact study period) and.
***[12] The Netherlands Perinatal Registry (LVR-2, 2005).
doi:10.1371/journal.pone.0056494.t004
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birthday, compared to only 2.3% in 1970.[19] Increasing
maternal age and in addition an unhealthy cardiovascular lifestyle
have brought along an increased prevalence of chronic medical
conditions such as obesity, hypertension and diabetes and
concomitantly more cardiovascular complications such as acute
coronary syndrome and (pre)eclampsia during pregnancy.[20]
The strength of this study is that cardiovascular disorders were
extracted from the first nationwide study of severe maternal
morbidity in the Netherlands and to date, the largest prospective
study in literature. This prospective design makes this study unique
but comparison with other studies unsound. Before relating our
results to those of other countries, it should be noted that these
results might not be directly comparable to the Dutch situation
because of differences in baseline demographics, health and
obstetric practices in our country. Especially the use of caesarean
section is relatively low in our country and delivery at home is still
common.
In the United States, a large National Hospital Discharge
Survey identified severe maternal morbidity because of cardiac
disease during delivery hospitalisations between 1991 and 2003 in
0.41 per 1000 deliveries and 6,7% of all SAMM as compared to
0.23 per 1000 deliveries and 3.3% of all SAMM in our study.[21]
Two other large European studies addressing overall incidence
of severe maternal morbidity in Western countries did not
separately specify cardiovascular disease.[22,23] A large retro-
spective cohort in Canada, showed a significantly increased
myocardial infarction rate from 0.00 to 0.02 per 1000 deliveries
between the triennium ending in 1993 and in 2000 giving a RR of
3.70 (95% CI 1.21–11.35).[24]
In 11 of 84 cases (13%), severe adverse effects of drugs have
likely played a role in our study. IHD and pulmonary oedema
after the use of ritodrine (Pre-Par) has been described in several
case reports.[25–28] In our study, three women experienced IHD
and one experienced PPCM after the use of ritodrine. As oxygen
consumption increases during pregnancy, addition of b-receptor
stimulation, further increasing oxygen consumption, may induce
IHD. IHD, coronary spasms and pulmonary oedema after the use
of sulproston (Nalador) has also been described in several case
reports.[29–31] In our study, i.v. administration of sulproston was
associated with cardiac problems in 7 women: IHD (n= 4), PPCM
(n=1), SVT (n= 1), and mitral valve regurgitation (n = 1).
However, the drug was administered after major obstetric
haemorrhage in all seven cases, with a median blood loss of
2,5 litres (range 1,5 to 5 litres) and a median transfusion of five red
blood cell units (range 4 to 10 units). It is uncertain if IHD was
caused by the haemorrhage leading to hypovolemia with
subsequent ischaemia or solely due to the administration of
sulproston. In cases with relatively little blood loss, the complica-
tion is more likely caused by sulproston. Pre-existing cardiac
disease is a strong contra-indication for administering these drugs,
and awareness of cardiac side effects is necessary when adminis-
tering these drugs even in the absence of cardiac disease. Even
though the Dutch authority for drug administration contraindi-
cates sulproston administration to women with cardiovascular
disease, the drug was administered to one woman with known
mitral valve insufficiency after major obstetric haemorrhage, albeit
without subsequent complications.[32]
Peripartum cardiomyopathy was preceded by hypertensive
disorders or pre-eclampsia in 10 of the 17 women giving an
identifiable cause for heart failure. It seems important for the
prognosis of future pregnancies to distinguish whether or not heart
failure was preceded by pregnancy induced hypertensive disorders
as a cause for PPCM.[33]
Overall, cardiovascular complications occurred after major
obstetric haemorrhage in 13 women. Within the LEMMoN-study
13 of the 1590 women (0.8%) with major obstetric haemorrhage
developed cardiac complications. Although not primarily a cardiac
complication, hemodynamic changes of pregnancy may cause
inadequate hemodynamic compensation for major haemorrhage
leading to severe cardiac complications.
The diagnosis of cardiomyopathy is more difficult in pregnancy
because of a more extensive differential diagnosis, including
normal left ventricular dilatation during pregnancy, amniotic fluid
embolism, pulmonary embolism, pre-eclampsia and placental
abruption. Amniotic fluid embolism or pulmonary embolism was
considered in three and seven women with acute dyspnoea,
respectively.
Vascular dissections including aortic and coronary dissections
were the main contributor to maternal mortality by cardiovascular
disease in our study and are further described by la Chapelle et al.
over a period of 15 years in the Netherlands.[34]
Measures such as primary epidural anaesthesia with or without
primary instrumental delivery, restriction of the duration of the
second stage of labour and elective caesarean section were agreed
upon by obstetricians and cardiologists or anaesthesiologists in
order to reduce variations in blood pressure and thus cardiac
strain. Cardiac monitoring during delivery was also warranted in
specific cases.
Caesarean section as mode of delivery during this study was
found to be a possible risk factor for cardiovascular disease. Of the
46 women who delivered by caesarean, 19 women developed
cardiovascular disease during or after caesarean section. It is
possible that caesarean sections, associated with hemodynamic
fluctuations associated with intubation, analgesia and choice of
anaesthesia and haemorrhage, aggravated maternal condition
leading to cardiovascular disease. For example, epidural anaes-
thesia gives significant peripheral vasodilation with subsequent
hypotension, which may trigger ischaemic heart disease. However,
we can not exclude the possibility that more symptomatic patients
have received caesarean sections because of their condition.
Non-Western immigrants comprise nearly a third (29%) of our
cohort, compared with 17% percent of the general population.
Non-Western immigrants thereby contribute substantially to the
incidence of severe morbidity from cardiovascular disease,
especially diseases preceded by rheumatic fever (n = 4). A general
medical check up in recently immigrated women may signal risk
factors or disease and improve maternal health through adequate,
early, education.
Other high-risk groups are obese women, women with a prior
caesarean delivery, women with multiple pregnancies and
nulliparous women. Obesity is not only a cardiac, but also an
obstetric problem and should be addressed by both national
campaigns to improve general health as well as by counselling in
early, or preferably before, pregnancy. Preventing a first caesarean
delivery leads to less morbidity in subsequent pregnancies and
opting for caesarean section should therefore be weighed carefully
when the indication is not strict. In case of artificial reproduction,
preventing multiple gestations is extremely important, leading to
less maternal and neonatal morbidity and mortality. Physicians
should have increased awareness for development of cardiovascu-
lar disease in these high risk groups and should hold a low
threshold for adequate early pregnancy screening and referral to a
cardiologist and/or anaesthesiologist early in pregnancy and at
least prior to delivery.
Women with pre-existing cardiac disease should be referred for
preconceptional advice, optimising preconceptional health and
staying within scope throughout pregnancy in a specialised centre.
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As conditions may worsen, preconceptional advice is also indicated
in women with pre-existing cardiac disease who have already had
uneventful pregnancies and deliveries in the past. In our cohort,
based on the available information from photocopied files, only a
low percentage of women with pre-existing cardiac disease actually
did have preconceptional advice. In our opinion, women with a
cardiac family history and women who have had chemotherapy in
childhood should also be eligible for preconceptional screening
with echocardiography and advice afterwards.
Delay in treatment may be the result of numerous factors. First
of all, the family history is often only partially known or told by the
patient or not asked for in detail by the physician leading to
inadequate information for risk assessment. Secondly, pregnant
women, especially nulliparous, may attribute symptoms to
pregnancy until they have aggravated so severely that adequate
treatment is out of reach. In addition, symptoms may not always
be taken seriously by health care providers, adding to a delay in
diagnosis and treatment. For example, symptoms of shortness of
breath and increasing fatigue may accompany uncomplicated
pregnancy but are also symptoms of coronary heart disease.
Sometimes, no clarifications for existing symptoms may be found
despite adequate investigations, giving false reassurance. When
there is a high index of suspicion, it is imperative that symptoms be
taken seriously and pathology is excluded, and that women are
told to contact their physician in case of recurrent or persisting
symptoms. A delay in diagnosis or treatment may also have
occurred due to communication difficulties among the Non-
Western women concerning access to care.
The results of this study should increase awareness of the
occurrence of severe maternal morbidity from cardiovascular
disease and will hopefully lead to adequate risk assessment and
timely referral of women at risk. The ZAHARA-II study group
and the European Society of Cardiology are currently performing
more research on pregnancy and acquired and congenital
cardiovascular disease.
Study limitations
The main limitation of this study is that we were dependent
upon the selection of women and the information that was
submitted by the local coordinating obstetrician. While these were
all very dedicated abstractors, objective inclusion criteria were
lacking therefore leaving inclusions of rare conditions of severe
maternal morbidity as well as severe manifestations of generally
less severe conditions up to the opinion of the treating obstetrician.
These factors may contribute to bias and underestimation.
Potentially missing cases most likely concern women with less
severe morbidity, as opposed to those with severe morbidity.
Morbidity is difficult to classify, with a wide range of severity all
considered ‘morbidity’.
Although extensive general and obstetric information was
usually present in every case, specific detailed cardiologist reports,
ICU records or follow-up letters concerning cardiac risk factors
were not complete in all cases. This sometimes complicated the
process of classifying cases based on the correct diagnosis and
could possibly skew the distribution of causes of cardiovascular
disorders as seen in Table 1. Information on certain cardiac risk
factors was missing such as smoking (31%) and BMI (25%).
Another limitation is that individual characteristics of all
maternities without severe maternal morbidity during the study
period were not available. Therefore, we could not adjust relative
risks for confounding variables, nor was a multivariable analysis
possible. Case ascertainment cannot be guaranteed but is
considered accurate. Especially the most severe cases of cardiac
complications are unlikely to be missed. Postpartum complications
that occurred more remote from delivery, however, could have
been missed as they might stay out of the scope of the obstetrician.
An important limitation is that women with pre-existing
acquired or congenital heart disease who did not experience
severe maternal morbidity were not captured in this study. This
makes it impossible to calculate the chance of severe morbidity for
all women with pre-existing acquired or congenital heart disease in
general. It should therefore be noted that the mentioned CFRs is
of limited use, as it is based on women with severe maternal
morbidity from cardiovascular disease only.
Conclusion
Cardiovascular disease is a rare cause of severe maternal
morbidity with a high case fatality rate, especially in the case of
aortic dissection. Most cardiac disorders in pregnancy, delivery or
puerperium develop in women without pre-existing cardiac
disease. In 13% of cases a serious adverse event of drugs might
have played a crucial role in the development of the complication.
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